9amHealth

What 9amHealth does

9amHealth is a US-based virtual specialty care provider founded in 2021 and headquartered in San Diego/Encinitas, California, delivering integrated cardiometabolic care — weight management, diabetes prevention and treatment, and heart health — to individuals, employers, health plans, and pharmacy benefit managers across 47 states plus Washington, D.C. The platform pairs board-certified obesity specialists, endocrinologists, pharmacists, dietitians, and behavioral health experts with prescription medications including GLP-1s, at-home lab testing, and connected devices (cellular scales, blood pressure monitors via Withings Health Solutions) to deliver measurable clinical outcomes, including a reported 17.6% average weight reduction with GLP-1s over 12 months, 2.8-point A1c reduction in poorly controlled members, and 19.8 mmHg blood pressure reduction in hypertensive members.

The underlying technology is an AI-enabled virtual care platform that processes structured patient data (weight, body composition, blood pressure, lab results) to support clinical workflows, personalize treatment plans, and generate projected medical and pharmacy savings — reportedly exceeding $50M across two Fortune 100 employers. The platform is offered as a subscription on a quote-based model to enterprise buyers and via a direct-to-consumer channel through web and mobile applications (iOS and Android).

9amHealth monetizes through four subscription/recurring revenue streams: (1) employer health benefits programs including the 'No-Barriers Bundle' offering FDA-approved obesity medications from Eli Lilly and Novo Nordisk; (2) health plan partnerships integrating virtual specialty care into covered benefits; (3) pharmacy benefit manager partnerships for specialty pharmacy cost management; and (4) direct-to-consumer subscriptions. The company has raised approximately $54.7 million across four funding rounds (seed $3.7M in 2021, Series A $16M in 2022, Series A extension $9.5M in 2024 led by Cigna Ventures, and Series B $26M in 2026 led by Define Ventures), with strategic distribution partnerships including Eli Lilly's Employer Connect platform and Amazon Pharmacy.

Name

9amHealth

Legal name

9AMHEALTH INC.

Website

https://9am.health

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

251–500 employees

Short description

9amHealth is a US virtual specialty care provider founded in 2021 delivering integrated cardiometabolic care — weight management, diabetes, and heart health — to consumers, employers, health plans, and PBMs across 47 states through an AI-enabled platform combining prescriptions, connected devices, and at-home labs.

Ownership category

akta.pro rank

Product category

Virtual Cardiometabolic Care

NAICS

Offices of Physicians (6211), Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Virtual Specialty Care Programs (Payer-Sponsored) (HLALACAD), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK), Membership/Subscription Concierge Virtual Care (HLALAAAH)

Keywords

• Virtual cardiometabolic care
• Weight management programs
• Diabetes management platform
• Heart health services
• Employer health benefits

Headquarters

HQ city

Encinitas

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Employer Health Benefits: B2B revenue from employers providing cardiometabolic care as an employee health benefit. Employers pay for access to the platform and care services to manage rising GLP-1 medication costs and improve workforce health outcomes.
2. Health Plan Partnerships: Revenue from health insurance plans that incorporate 9amHealth's virtual specialty care into their covered benefits for members with diabetes, obesity, and cardiovascular conditions.
3. PBM Integration: Revenue from pharmacy benefit managers seeking integrated cardiometabolic care solutions to manage specialty pharmacy costs and medication adherence.
4. Direct-to-Consumer Subscription: Individual consumers pay for personalized diabetes care, medication management, and weight loss programs including prescription medications, at-home testing, and specialist access.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels4 records

Core offering

9amHealth delivers a virtual specialty care platform that provides integrated cardiometabolic care spanning weight management, diabetes, and heart health. Members receive personalized treatment plans, prescription medications (including GLP-1s when indicated), at-home lab testing, connected-device remote monitoring, and 24/7 access to a multidisciplinary care team of board-certified obesity specialists, pharmacists, dietitians, and behavioral health experts, delivered through web and mobile channels.

Product overview

9amHealth is a virtual healthcare platform providing integrated cardiometabolic care through three core product lines: Weight Management, Diabetes Care, and Heart Health. The platform operates as a unified care ecosystem offering connected devices (scales, blood pressure monitors), at-home lab tests, prescription medications, and access to board-certified obesity specialists. The No-Barriers Bundle is an employer-facing add-on that bundles FDA-approved obesity medications from major pharmaceutical partners with the core care platform. The company serves both direct-to-consumer and employer/health plan markets across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Weight Management Specialized virtual care program pairing prescription medications (including GLP-1s such as Zepbound and Wegovy when indicated) with nutrition, exercise, and behavioral support to deliver sustainable weight-loss outcomes. Includes connected scales and blood pressure monitors, at-home lab testing, and access to obesity specialists. Targeted at individuals with obesity and employer populations seeking to manage GLP-1 utilization.
• Diabetes Care Comprehensive virtual care for preventing, managing, and treating diabetes, including prediabetes, type 2 diabetes, and the Medicare Diabetes Prevention Program. Provides personalized treatment plans, prescription medications, at-home diagnostics (A1c testing kits), monitoring kits, and access to specialists. Targeted at adults with or at risk of diabetes and Medicare beneficiaries eligible for the MDPP under the PREVENT DIABETES Act.
• Heart Health Virtual care program for high blood pressure (hypertension) and high cholesterol (dyslipidemia) management designed to reduce cardiovascular events. Includes prescription medications, connected blood pressure monitors, at-home lab testing, and coordinated access to specialists. Targeted at adults with elevated cardiovascular risk.
• No-Barriers Bundle (Employer Health Benefit) Employer-sponsored health benefit that bundles FDA-approved obesity medications from Eli Lilly (Zepbound) and Novo Nordisk (Wegovy) with the full 9amHealth cardiometabolic care platform (connected devices, at-home labs, specialists, personalized care plans). Designed as an outcomes-driven, transparent alternative to traditional PBM obesity medication coverage for self-insured employers and their employees.
• 9amHealth Mobile App iOS and Android application that allows members to enroll, complete health evaluations, track weight/blood pressure/A1c metrics, message the care team, receive prescriptions, and access their personalized care plan across Weight Management, Diabetes Care, and Heart Health programs.

Quantifiable outcome

• 17.6% average weight reduction with GLP-1s over 12 months
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and major.

• Eli Lilly Employer ConnectcoreGTM or Marketing Partner · 5 March 20269amHealth is one of over 15 independent program administrators on Eli Lilly's Employer Connect platform, offering Zepbound KwikPen at $449 per dose. The platform addresses obesity medication coverage gaps for employers, with approximately half of commercially insured employees lacking coverage for these treatments.
• HealthDyne PharmacymajorChannel Partner/ Reseller/ Distributor · 5 March 2026Pharmacy dispensing partner within the Eli Lilly Employer Connect ecosystem providing medication fulfillment for employer-sponsored obesity care programs.
• CenterWell PharmacymajorChannel Partner/ Reseller/ Distributor · 5 March 2026Pharmacy dispensing partner within the Eli Lilly Employer Connect ecosystem providing medication fulfillment for employer-sponsored obesity care programs.
• Withings Health SolutionsmajorTechnology or Integration · 4 March 2026Partnership announced on World Obesity Day to provide body composition monitoring. 9amHealth members receive Body Pro 2 cellular scales and BPM Pro 2 blood pressure monitors, enabling care teams to access real-time patient data including weight, body composition, and health trends to support safer prescribing and more effective weight care.
• Amazon PharmacymajorGTM or Marketing Partner · 9 January 2026Collaboration to expand access to weight management treatments. 9amHealth is working with Amazon Pharmacy which now offers Novo Nordisk's Wegovy oral pill alongside other telehealth providers including WeightWatchers and Wheel.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Virta Health: Virta Health is a virtual type 2 diabetes reversal and cardiometabolic care platform serving employers, health plans, and PBMs. It is the closest direct competitor to 9amHealth, with overlapping GLP-1-enabled weight loss, diabetes, and metabolic health programs sold through enterprise B2B contracts.
• Omada Health: Omada Health is a virtual-first chronic care platform covering diabetes prevention, diabetes management, hypertension, and behavioral health, sold primarily to employers and health plans. It directly competes with 9amHealth in employer-sponsored cardiometabolic care and has a longer operating history.
• Calibrate: Calibrate is a metabolic health platform combining clinician-supervised care with GLP-1 medications for weight loss, sold to both consumers and enterprise. It overlaps with 9amHealth on the employer weight management and metabolic health offering.
• Found: Found is a telehealth weight care provider combining medication (including GLP-1s) with coaching and clinician support. It is a direct competitor to 9amHealth in virtual weight management, with a similar D2C-plus-enterprise motion.
• Hims & Hers Health: Hims & Hers is a consumer telehealth platform that has expanded aggressively into weight loss via GLP-1 prescribing. It competes with 9amHealth for D2C cardiometabolic and weight loss consumers, and increasingly for employer-sponsored programs.
• Ro: Ro is a direct-to-patient telehealth and pharmacy company that operates a weight loss program (Ro Body) using GLP-1s alongside its broader men's and women's health offerings. It overlaps with 9amHealth on virtual weight management and the pharmacy-plus-clinician delivery model.
• Noom: Noom is a digital weight loss platform that has added a clinical / medication-assisted weight management arm (Noom Med). It competes with 9amHealth in employer-sponsored and consumer weight management, with a stronger consumer brand but less clinical depth.

Broad incumbents

• WW International (WeightWatchers): WW International operates the WeightWatchers clinical weight management program incorporating GLP-1 access via Sequence/Wegovy partnerships. It is a broader incumbent in weight management that now competes with 9amHealth in medication-enabled virtual weight care for both consumers and employers.
• Teladoc Health: Teladoc Health is a broad telehealth incumbent offering virtual primary care, chronic condition management (including diabetes via the former Livongo), and mental health to employers and health plans. It is a broad incumbent competitor to 9amHealth in employer virtual care, though less focused on cardiometabolic specialty.

Emerging players

• Lark Health: Lark Health is an AI-driven virtual chronic disease management platform covering diabetes, hypertension, and prediabetes prevention, sold to health plans and employers. It overlaps with 9amHealth in employer-sponsored cardiometabolic virtual care and RPM-enabled coaching.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/9am_health
• LinkedInlinkedin.com/company/9amhealth
• Facebookfacebook.com/9amhealthofficial

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds6 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 9amHealth